Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
61
SGHT Quote, Financials, Valuation and Earnings
Last price:
$8.45
Seasonality move
:
9.54%
Day range:
$8.30 - $8.56
52-week range:
$2.03 - $8.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.73x
P/B ratio:
6.95x
Volume:
525.5K
Avg. volume:
263.8K
1-year change:
151.49%
Market cap:
$446.8M
Revenue:
$79.9M
EPS (TTM):
-$0.90
Analysts' Opinion
-
Consensus RatingSight Sciences, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $7.85, Sight Sciences, Inc. has an estimated downside of -7.1% from its current price of $8.45.
-
Price Target UpsideAccording to analysts, the highest upside price target is $12.00 representing -100% upside increase from its current price of $8.45.
Fair Value
-
According to the consensus of 7 analysts, Sight Sciences, Inc. has -7.1% downside to fair value with a price target of $7.85 per share.
SGHT vs. S&P 500
-
Over the past 5 trading days, Sight Sciences, Inc. has overperformed the S&P 500 by 4.21% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Sight Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sight Sciences, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Sight Sciences, Inc. reported revenues of $19.9M.
Earnings Growth
-
Sight Sciences, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Sight Sciences, Inc. reported earnings per share of -$0.16.
Enterprise value:
395.1M
EV / Invested capital:
3.76x
Price / LTM sales:
5.73x
EV / EBIT:
--
EV / Revenue:
5.19x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$65.4M
Return On Assets:
-35.23%
Net Income Margin (TTM):
-60.63%
Return On Equity:
-58.45%
Return On Invested Capital:
-38.96%
Operating Margin:
-39.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $82.8M | $79.5M | $76.1M | $20.2M | $19.9M | |
| Gross Profit | $70.1M | $67.7M | $65.4M | $16.9M | $17.2M | |
| Operating Income | -$63.2M | -$49.7M | -$45.4M | -$11.2M | -$7.9M | |
| EBITDA | -$62M | -$49.1M | -$44.8M | -$11.1M | -$7.8M | |
| Diluted EPS | -$1.28 | -$1.01 | -$0.90 | -$0.22 | -$0.16 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $287.8M | $222.3M | $173.6M | $140.5M | $113.6M | |
| Total Assets | $291.1M | $225.2M | $176.6M | $143.6M | $116.3M | |
| Current Liabilities | $10.3M | $17.4M | $14.3M | $13.8M | $11.8M | |
| Total Liabilities | $45.1M | $52.3M | $49.6M | $48.6M | $52M | |
| Total Equity | $246M | $172.9M | $127.1M | $95M | $64.3M | |
| Total Debt | $34.2M | $33.8M | $33.8M | $34.8M | $40.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$56.2M | -$25.6M | -$31.1M | $362K | -$8.7M | |
| Cash From Investing | -$656K | -$512K | -$517K | -$51K | -$170K | |
| Cash From Financing | $1.5M | $189K | $5.7M | $76K | $25K | |
| Free Cash Flow | -$56.9M | -$26.1M | -$31.6M | $311K | -$8.9M | |
SGHT
Sector
Market Cap
$446.8M
$28.3M
Price % of 52-Week High
96.02%
51.3%
Dividend Yield
0%
0%
Shareholder Yield
-1.17%
-1.42%
1-Year Price Total Return
151.49%
-17.78%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$8.30
200-day SMA
Buy
Level
$4.20
Bollinger Bands (100)
Buy
Level
3.26 - 6.98
Chaikin Money Flow
Sell
Level
-155.2K
20-day SMA
Buy
Level
$8.21
Relative Strength Index (RSI14)
Buy
Level
62.93
ADX Line
Buy
Level
19.93
Williams %R
Neutral
Level
-35.4736
50-day SMA
Buy
Level
$6.52
MACD (12, 26)
Buy
Level
1.56
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
551.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.947)
Sell
CA Score
(Annual)
Level (-0.9487)
Buy
Beneish M-Score
(Annual)
Level (-3.8498)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.0411)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Stock Forecast FAQ
In the current month, SGHT has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The SGHT average analyst price target in the past 3 months is $7.85.
-
Where Will Sight Sciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sight Sciences, Inc. share price will drop to $7.85 per share over the next 12 months.
-
What Do Analysts Say About Sight Sciences, Inc.?
Analysts are divided on their view about Sight Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sight Sciences, Inc. is a Sell and believe this share price will rise from its current level to $5.00.
-
What Is Sight Sciences, Inc.'s Price Target?
The price target for Sight Sciences, Inc. over the next 1-year time period is forecast to be $7.85 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is SGHT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sight Sciences, Inc. is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SGHT?
You can purchase shares of Sight Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sight Sciences, Inc. shares.
-
What Is The Sight Sciences, Inc. Share Price Today?
Sight Sciences, Inc. was last trading at $8.45 per share. This represents the most recent stock quote for Sight Sciences, Inc.. Yesterday, Sight Sciences, Inc. closed at $8.45 per share.
-
How To Buy Sight Sciences, Inc. Stock Online?
In order to purchase Sight Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SGHT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SGHT
Sector
P/E ratio
--
23.99x
PEG ratio
--
-0.01x
P/B ratio
6.95x
1.80x
Price / LTM sales
5.73x
1.59x
Growth Metrics
SGHT
Sector
Revenue growth
-1.25%
4.62%
Earnings growth
29.03%
10.71%
Revenue (5-year growth)
27.89%
6.5%
Earnings forecast
-$0.26
-$0.20
Profitability
SGHT
Sector
Profitability FY 2024
$68.3M
$3.6M
Return on invested capital
-38.96%
-31.84%
Return on assets
-35.23%
-27.96%
Return on equity
-58.45%
-37.47%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
SGHT
Sector
Total cash
$92.4M
$26.4M
Short term investments
--
$25.7M
Total assets
$142.8M
$78M
Long term debt
$40.1M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
